ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,060,000 | -48.1% | 1,330,370 | -0.9% | 0.00% | -100.0% |
| Q2 2021 | $5,895,000 | -39.8% | 1,342,858 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $9,798,000 | +67.9% | 1,349,531 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $5,836,000 | -54.1% | 1,350,835 | -56.3% | 0.00% | 0.0% |
| Q3 2020 | $12,713,000 | -56.9% | 3,093,170 | -37.0% | 0.00% | -75.0% |
| Q2 2020 | $29,479,000 | -10.1% | 4,913,115 | +12.8% | 0.00% | -20.0% |
| Q1 2020 | $32,806,000 | -56.4% | 4,356,698 | -20.3% | 0.01% | -50.0% |
| Q4 2019 | $75,205,000 | +27.8% | 5,469,458 | +10.4% | 0.01% | +25.0% |
| Q3 2019 | $58,862,000 | +4.0% | 4,954,677 | +22.4% | 0.01% | 0.0% |
| Q2 2019 | $56,611,000 | +55.9% | 4,046,558 | +99.3% | 0.01% | +60.0% |
| Q1 2019 | $36,309,000 | +20.8% | 2,030,688 | +6.2% | 0.01% | 0.0% |
| Q4 2018 | $30,068,000 | – | 1,911,531 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |